Trial Profile

A clinical trial of BMC 333 for Inflammatory-bowel-diseases

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 02 May 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

27 Apr 2023 According to Biomica media release, company has successfully closed $20 million financing round led by Shanghai Healthcare Capital. The proceeds will be utilized to scale up, complete GMP production and also in preparation for a phase I clinical trial for treatment of inflammatory bowel disease (IBD).
15 Mar 2022 New trial record
10 Mar 2022 According an Evogene media release, company plans initiation of this clinical trial in 2022.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com